KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $854.4 million.

  • Medpace Holdings' Current Deferred Revenue rose 2023.76% to $854.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $854.4 million, marking a year-over-year increase of 2023.76%. This contributed to the annual value of $854.4 million for FY2025, which is 2023.76% up from last year.
  • According to the latest figures from Q4 2025, Medpace Holdings' Current Deferred Revenue is $854.4 million, which was up 2023.76% from $834.3 million recorded in Q3 2025.
  • Medpace Holdings' 5-year Current Deferred Revenue high stood at $854.4 million for Q4 2025, and its period low was $277.8 million during Q1 2021.
  • Its 5-year average for Current Deferred Revenue is $537.3 million, with a median of $504.7 million in 2023.
  • In the last 5 years, Medpace Holdings' Current Deferred Revenue soared by 4996.55% in 2021 and then skyrocketed by 1654.28% in 2025.
  • Medpace Holdings' Current Deferred Revenue (Quarter) stood at $344.6 million in 2021, then soared by 34.26% to $462.7 million in 2022, then grew by 20.99% to $559.9 million in 2023, then rose by 26.92% to $710.6 million in 2024, then increased by 20.24% to $854.4 million in 2025.
  • Its Current Deferred Revenue was $854.4 million in Q4 2025, compared to $834.3 million in Q3 2025 and $808.8 million in Q2 2025.